Overall num. Patients | Num. patients treated with efmoroctocog alfa | Cost CE (Euro) | Cost NE (Euro) | Savings (Euro) | % Savings | |
---|---|---|---|---|---|---|
Year 1 | ||||||
Pediatrics | 169 | 17 | 11,812,558 | 11,686,364 | 126,194 | 1.1% |
Adults | 691 | 69 | 172,352,752 | 169,523,751 | 2,829,001 | 1.6% |
Total | 860 | 86 | 184,165,311 | 181,210,115 | 2,955,196 | 1.6% |
Year 2 | ||||||
Pediatrics | 170 | 26 | 11,871,934 | 11,681,691 | 190,243 | 1.6% |
Adults | 694 | 104 | 173,219,079 | 168,954,248 | 4,264,831 | 2.5% |
Total | 864 | 130 | 185,091,013 | 180,635,939 | 4,455,074 | 2.4% |
Year 3 | ||||||
Pediatrics | 171 | 34 | 11,931,608 | 11,676,676 | 254,932 | 2.1% |
Adults | 698 | 140 | 174,089,760 | 168,374,735 | 5,715,025 | 3.3% |
Total | 869 | 174 | 186,021,368 | 180,051,411 | 5,969,957 | 3.2% |
Total | ||||||
Pediatrics | 510 | 77 | 35,616,100 | 35,044,731 | 571,369 | 1.6% |
Adults | 2083 | 313 | 519,661,591 | 506,852,735 | 12,808,856 | 2.5% |
Total | 2593 | 390 | 555,277,691 | 541,897,466 | 13,380,225 | 2.4% |